Two Sigma Securities LLC bought a new position in Zoetis Inc (NYSE:ZTS) during the fourth quarter, Holdings Channel reports. The fund bought 6,261 shares of the company’s stock, valued at approximately $451,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in ZTS. Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Zoetis in the 4th quarter worth approximately $108,000. Steward Partners Investment Advisory LLC bought a new stake in shares of Zoetis in the 3rd quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of Zoetis by 251.9% in the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock worth $121,000 after purchasing an additional 1,360 shares in the last quarter. Premia Global Advisors LLC bought a new stake in shares of Zoetis in the 4th quarter worth approximately $122,000. Finally, Icon Wealth Partners LLC bought a new stake in shares of Zoetis in the 4th quarter worth approximately $127,000. Institutional investors and hedge funds own 92.45% of the company’s stock.
In related news, insider Roman Trawicki sold 8,568 shares of the business’s stock in a transaction that occurred on Friday, March 9th. The shares were sold at an average price of $83.10, for a total transaction of $712,000.80. Following the transaction, the insider now directly owns 11,457 shares of the company’s stock, valued at $952,076.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Roxanne Lagano sold 35,663 shares of the business’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $81.02, for a total transaction of $2,889,416.26. Following the transaction, the executive vice president now directly owns 49,919 shares in the company, valued at $4,044,437.38. The disclosure for this sale can be found here. Insiders have sold 105,569 shares of company stock worth $8,594,429 over the last ninety days. 0.31% of the stock is currently owned by insiders.
Zoetis Inc (NYSE ZTS) opened at $84.59 on Wednesday. Zoetis Inc has a 1 year low of $52.25 and a 1 year high of $85.54. The company has a market cap of $40,960.27, a P/E ratio of 48.34, a P/E/G ratio of 1.89 and a beta of 0.97. The company has a current ratio of 3.85, a quick ratio of 2.55 and a debt-to-equity ratio of 2.77.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 15th. The company reported $0.69 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.03. Zoetis had a net margin of 16.28% and a return on equity of 65.96%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same period in the previous year, the firm posted $0.47 earnings per share. The firm’s revenue was up 14.3% on a year-over-year basis. equities analysts anticipate that Zoetis Inc will post 3.04 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, April 20th will be given a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Thursday, April 19th. Zoetis’s payout ratio is presently 28.57%.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.